Natrelle® Secures Major Deal with Vizient, Expanding Breast Implant Access
Allergan Aesthetics, an AbbVie company, has secured a significant deal for their leading breast implant brand, Natrelle®. Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company, has named Natrelle® as a supplier. This agreement expands Natrelle®'s reach and offers enhanced access to its extensive range of breast implant options.
Natrelle®, already the top choice among plastic surgeons, will now be available to a broader range of healthcare providers through Vizient's extensive network. This includes academic medical centers, community hospitals, and integrated delivery networks, covering over half of U.S. healthcare organizations.
The agreement brings competitive pricing and a simplified procurement process, along with direct support from Natrelle®'s experienced sales and technical teams. Providers will benefit from over 300 implant options within the brand's comprehensive line, catering to diverse patient needs.
Glen Curran, Senior Vice President, U.S., Allergan Aesthetics, expressed the company's commitment to supporting women through their breast reconstruction journeys and equipping providers with the necessary tools for exceptional care.
With this agreement, Natrelle® strengthens its position as the leading breast implant brand, expanding its reach to more healthcare providers and patients. The deal offers competitive pricing, simplified procurement, and a wide range of implant options, further cementing Natrelle®'s commitment to safety, science, and aesthetics in breast reconstruction.
Read also:
- Intestinal Infection Causing Stomach Distress: Signs and Remedies
- What is the expected timing for the flu season in this current year?
- Essential Information on Cushing Syndrome: a Disorder Caused by High Cortisol Levels
- Starting in September, elderly individuals aged 75 years and above will be enrolled in a preventive program for Respiratory Syncytial Virus (RSV).
